Smith Hayes Advisers’s Amgen AMGN Stock Holding History

Smith Hayes Advisers’s Portfolio AMGN Stock Details AMGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q1	$288K	Buy	1,919 +8	+0.4%	+$1.19K	0.06%	260
2015 Q4	$310K	Buy	1,911 +21	+1%	+$3.3K	0.07%	252
2015 Q3	$261K	Sell	1,890 -69	-4%	-$10.9K	0.06%	255
2015 Q2	$301K	Buy	1,959 +310	+19%	+$49.7K	0.06%	255
2015 Q1	$264K	Buy	1,649 +116	+8%	+$18.3K	0.05%	273
2014 Q4	$244K	Sell	1,533 -79	-5%	-$12.3K	0.05%	269
2014 Q3	$226K	Sell	1,612 -454	-22%	-$59.3K	0.05%	259
2014 Q2	$245K	Buy	+2,066	New	+$239K	0.06%	251

Other funds holding AMGN

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

Smith Hayes Advisers's AMGN Position: Q1 2016 in Review

Smith Hayes Advisers increased its Amgen (AMGN) stake by 0.42% in Q1 2016, buying an estimated $1.19K and bringing the position to 1,919 shares worth $288K. The position accounts for 0.06% of the portfolio, ranked #260.

Smith Hayes Advisers first reported a position in AMGN in Q2 2014 and has held it in 8 quarters since. The position peaked at $310K in Q4 2015. 1,434 funds tracked by Wall St. Rank hold AMGN as of Q1 2016.

Smith Hayes Advisers held 1,919 shares of Amgen worth $288K as of Q1 2016.
Smith Hayes Advisers bought 8 Amgen shares in Q1 2016, an estimated $1.19K.
Amgen made up 0.06% of Smith Hayes Advisers's portfolio in Q1 2016, its #260 holding.
Smith Hayes Advisers first reported a position in Amgen in Q2 2014 and has held it in 8 quarters since.
Smith Hayes Advisers's Amgen position peaked at $310K in Q4 2015.
1,434 funds tracked by Wall St. Rank held Amgen as of Q1 2016.

Based on Smith Hayes Advisers's 13F filing for Q1 2016, filed 16 May 2016.